Zymeworks Inc.
NYSE:ZYME
16.77 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 76.012 | 412.482 | 26.68 | 38.951 | 29.544 | 53.019 | 51.762 | 11.009 | 9.66 | 1.67 |
| Cost of Revenue
| 142.989 | 208.703 | 199.539 | 170.896 | 117.096 | 56.926 | 41.144 | 35.551 | 24.403 | 10.473 |
| Gross Profit
| -66.977 | 203.779 | -172.859 | -131.945 | -87.552 | -3.907 | 10.618 | -24.542 | -14.743 | -8.803 |
| Gross Profit Ratio
| -0.881 | 0.494 | -6.479 | -3.387 | -2.963 | -0.074 | 0.205 | -2.229 | -1.526 | -5.271 |
| Reseach & Development Expenses
| 143.619 | 208.596 | 199.752 | 168.534 | 115.9 | 56.684 | 41.749 | 36.816 | 24.654 | 12.622 |
| General & Administrative Expenses
| 70.4 | 73.358 | 42.561 | 57.885 | 64.177 | 29.457 | 18.55 | 12.554 | 5.217 | 3.945 |
| Selling & Marketing Expenses
| -0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 70.4 | 73.358 | 42.561 | 57.885 | 64.177 | 29.457 | 18.55 | 12.554 | 5.217 | 3.945 |
| Other Expenses
| 0.291 | 4.706 | 3.274 | 7.345 | 5.282 | -1.258 | -0.964 | -1.265 | -0.251 | -2.149 |
| Operating Expenses
| 214.019 | 281.954 | 242.313 | 226.419 | 180.077 | 86.146 | 59.224 | 48.105 | 29.62 | 14.418 |
| Operating Income
| -138.053 | 130.528 | -215.633 | -187.468 | -151.301 | -33.127 | -8.998 | -37.864 | -19.96 | -12.748 |
| Operating Income Ratio
| -1.816 | 0.316 | -8.082 | -4.813 | -5.121 | -0.625 | -0.174 | -3.439 | -2.066 | -7.634 |
| Total Other Income Expenses Net
| -0.894 | 4.706 | 3.274 | 7.345 | 5.282 | -1.258 | -2.5 | -1.146 | 0.518 | -0.301 |
| Income Before Tax
| -119.242 | 135.234 | -212.359 | -180.123 | -146.019 | -34.385 | -9.962 | -38.884 | -19.136 | -12.942 |
| Income Before Tax Ratio
| -1.569 | 0.328 | -7.959 | -4.624 | -4.942 | -0.649 | -0.192 | -3.532 | -1.981 | -7.75 |
| Income Tax Expense
| -0.568 | 10.893 | -0.516 | 0.429 | -0.582 | 2.171 | 0.444 | -5.075 | 0.034 | -0.284 |
| Net Income
| -118.674 | 124.341 | -211.843 | -180.552 | -145.437 | -36.556 | -10.406 | -33.809 | -19.17 | -12.942 |
| Net Income Ratio
| -1.561 | 0.301 | -7.94 | -4.635 | -4.923 | -0.689 | -0.201 | -3.071 | -1.984 | -7.75 |
| EPS
| -1.72 | 1.91 | -4.06 | -3.58 | -3.83 | -1.26 | -0.49 | -1.72 | -0.97 | -0.65 |
| EPS Diluted
| -1.72 | 1.9 | -4.06 | -3.58 | -3.83 | -1.26 | -0.49 | -1.72 | -0.97 | -0.65 |
| EBITDA
| -119.517 | 130.528 | -215.633 | -187.468 | -149.765 | -33.127 | -5.926 | -36.26 | -19.142 | -12.513 |
| EBITDA Ratio
| -1.572 | 0.316 | -8.082 | -4.813 | -5.069 | -0.625 | -0.114 | -3.294 | -1.982 | -7.493 |